# Ovomucoid (Gallus gallus domesticus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ovomucoid
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** Gal d 1, Egg white ovomucoid, Chicken egg allergen, Trypsin inhibitor protein, Gallus domesticus ovomucoid, Ovomucoid protein

## Overview

Ovomucoid is a glycoprotein found in raw egg white that functions as a serine protease inhibitor, specifically blocking trypsin activity through three Kazal-type inhibitory domains. It is primarily characterized in scientific literature as a heat-stable major egg allergen rather than a beneficial dietary supplement.

## Health Benefits

• No therapeutic benefits documented - available research characterizes ovomucoid exclusively as a major egg allergen rather than a beneficial supplement
• Functions as a trypsin inhibitor through its three Kazal family inhibitory domains, though clinical applications remain unstudied
• Contains glycosylation at five sites with various carbohydrates, but biomedical benefits are not established in the literature
• Demonstrates high structural stability due to 9 disulfide bonds, though this property relates to allergenicity rather than therapeutic value
• No evidence of supplement efficacy - all available studies focus on its role in allergic sensitization

## Mechanism of Action

Ovomucoid inhibits serine proteases, particularly trypsin, through its three tandem Kazal-type inhibitory domains, which form stable non-covalent complexes with the protease active site, preventing substrate cleavage. Domain I preferentially inhibits elastase, Domain II inhibits trypsin and chymotrypsin, and Domain III inhibits trypsin, collectively disrupting pancreatic [digestive enzyme](/ingredients/condition/gut-health) function. The protein contains approximately 186 amino acid residues and is heavily glycosylated with N-linked oligosaccharide chains, which contribute to its thermal stability and allergenicity by maintaining epitope structure even after cooking.

## Clinical Summary

No clinical trials have investigated ovomucoid as a therapeutic supplement; its presence in research is confined almost entirely to allergy and food science contexts. Immunological studies have identified ovomucoid (Gal d 1) as the dominant allergen in hen egg white, with IgE-binding studies demonstrating it as the primary sensitizing protein in egg-allergic individuals, affecting an estimated 1.3–2.5% of children in Western populations. In vitro and animal studies confirm its trypsin inhibitor activity reduces protease-mediated [digestion](/ingredients/condition/gut-health) efficiency, but no human dosing studies, bioavailability data, or therapeutic outcome measures exist. The overall evidence base for any beneficial supplemental use is absent; available data exclusively characterize ovomucoid as a food allergen.

## Nutritional Profile

Ovomucoid is a glycoprotein comprising approximately 11% of total egg white protein by dry weight, with a molecular weight of ~28 kDa. Protein content constitutes roughly 75-80% of its molecular mass, with the remaining 20-25% composed of carbohydrate moieties. Amino acid composition is notable for high cysteine content (forming 9 disulfide bonds critical to its structural stability across three Kazal-type serine protease inhibitor domains), as well as moderate concentrations of serine, threonine, and asparagine residues that serve as glycosylation anchor points. Carbohydrate fraction includes mannose, galactose, N-acetylglucosamine, fucose, and sialic acid distributed across 5 N-linked and O-linked glycosylation sites; carbohydrate chain composition varies depending on hen breed, age, and diet. Contains all essential amino acids but is not consumed as an isolated macronutrient source in normal dietary contexts. Provides negligible micronutrient contribution when considered in isolation. Bioavailability as an intact protein is low under normal digestive conditions due to its inherent resistance to trypsin-mediated proteolysis — its primary characterized biochemical property — as well as partial resistance to pepsin and chymotrypsin, meaning it may transit the gastrointestinal tract in a structurally intact or semi-intact form, which is directly implicated in its allergenicity. Thermal stability is moderate; partial denaturation occurs at sustained high temperatures (>80°C), though glycosylation helps maintain structural integrity. No isolated micronutrient or mineral contributions have been quantified for ovomucoid as a standalone ingredient.

## Dosage & Preparation

No clinically studied dosage ranges for ovomucoid as a supplement are available in the scientific literature. The research does not address standardized extract forms, powder preparations, or dosing protocols for therapeutic use. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ovomucoid is the principal heat-stable allergen in egg white and remains allergenic even after boiling or baking, making it a significant risk for individuals with egg allergy who may react with symptoms ranging from urticaria and gastrointestinal distress to anaphylaxis. Its trypsin inhibitor activity theoretically could impair protein [digestion](/ingredients/condition/gut-health) and reduce absorption of protein-bound nutrients if consumed in sufficient quantities, though this has not been quantified in human studies. Individuals taking proteolytic enzyme supplements such as bromelain, papain, or pancreatin may experience reduced enzyme efficacy due to direct inhibition by ovomucoid's Kazal domains. No pregnancy-specific safety data exists, and its use is contraindicated in anyone with a diagnosed egg or egg white allergy.

## Scientific Research

The provided research contains no peer-reviewed clinical trials, RCTs, or meta-analyses examining ovomucoid as a therapeutic supplement. The only clinical study mentioned examined 18 children with egg allergy, demonstrating ovomucoid's potency as an allergen compared to ovalbumin through skin prick and IgE tests, highlighting its allergenic rather than therapeutic properties.

## Historical & Cultural Context

The research contains no information regarding historical or traditional use of ovomucoid in any medicine system. Its characterization in scientific literature focuses exclusively on its modern identification as an egg allergen.

## Synergistic Combinations

No synergistic ingredients identified in research

## Frequently Asked Questions

### Is ovomucoid safe to eat for people with egg allergies?

No. Ovomucoid (Gal d 1) is classified as the dominant heat-stable allergen in hen egg white and retains its IgE-binding epitopes after cooking, meaning baked or boiled egg products can still trigger allergic reactions in sensitized individuals. People with confirmed egg white allergy should avoid any product containing ovomucoid, as reactions can range from hives and gastrointestinal symptoms to life-threatening anaphylaxis.

### What enzyme does ovomucoid inhibit?

Ovomucoid primarily inhibits trypsin, a serine protease secreted by the pancreas, through its Kazal-type inhibitory domains — particularly Domain II and Domain III, which form tight-binding complexes with trypsin's catalytic site. Domain I additionally inhibits neutrophil elastase and chymotrypsin, making ovomucoid a broad-spectrum but low-potency serine protease inhibitor in the digestive tract.

### Does ovomucoid survive cooking?

Yes. Unlike many proteins, ovomucoid retains structural integrity and allergenic activity after heating because its heavily glycosylated N-linked oligosaccharide chains protect its core polypeptide epitopes from thermal denaturation. Studies measuring IgE reactivity confirm that ovomucoid extracted from hard-boiled or baked eggs still triggers immune responses in egg-allergic patients, distinguishing it from less stable egg proteins like ovalbumin.

### Can ovomucoid be used as a supplement for any health benefit?

There is no documented therapeutic or supplemental use for isolated ovomucoid in humans. All peer-reviewed research characterizes it as a food allergen or uses it as a biochemical tool to study serine protease inhibition; no clinical trials have tested it for any health outcome such as digestive support, anti-inflammatory effects, or immune modulation. Its risk profile as a potent allergen makes supplemental development unlikely.

### What is the difference between ovomucoid and ovalbumin?

Ovomucoid (Gal d 1) and ovalbumin (Gal d 2) are both major egg white proteins but differ significantly in structure and heat stability. Ovalbumin is a non-glycosylated phosphoprotein and the most abundant egg white protein (~54% of egg white protein content), while ovomucoid is a heavily glycosylated Kazal-type serine protease inhibitor comprising roughly 11% of egg white protein. Critically, ovalbumin loses its allergenicity upon extensive heating, whereas ovomucoid retains IgE-binding capacity after cooking, making it the more clinically significant allergen.

### What foods naturally contain ovomucoid?

Ovomucoid is found exclusively in egg white (albumen) from chicken eggs, where it comprises approximately 11% of the total protein content. It is one of the most abundant proteins in raw egg white and is present in both chicken and other bird eggs, though chicken eggs are the primary dietary source. The concentration of ovomucoid in eggs makes it impossible to avoid if you have a documented egg allergy, even with careful food selection.

### Is there clinical research supporting ovomucoid as a health supplement?

Current biomedical research does not document any therapeutic health benefits from ovomucoid supplementation. Existing scientific literature characterizes ovomucoid primarily as a major egg allergen and trypsin inhibitor, with no published clinical trials demonstrating efficacy for any health condition. While ovomucoid has been studied in laboratory settings for its protease-inhibiting properties, these findings have not translated into established clinical applications or supplement recommendations.

### What is the difference between ovomucoid and other egg white proteins?

Ovomucoid is structurally and functionally distinct from other egg white proteins like ovalbumin, lysozyme, and ovotransferrin primarily due to its three Kazal-family trypsin-inhibitor domains that give it protease-inhibiting activity. While ovalbumin is the most abundant egg white protein, ovomucoid is notable for being one of the most thermostable egg proteins and a major allergen recognized even in extensively heated egg products. Other egg proteins lack ovomucoid's characteristic inhibitory function and allergenicity profile.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*